{"entity":{"type":"insider","cik":"0001663041","url":"/insider/0001663041","json_url":"/insider/0001663041.json","name":"Bukofzer Stan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2016-10-17","last":"2019-08-14","span_basis":"filed_date"},"name_variants":[{"name":"Bukofzer Stan","source":"filing","n_filings":3,"first_seen":"2016-10-17","last_seen":"2019-08-14"}],"transactions":[{"id":8635802,"accession":"0001005201-19-000099","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000099","line_url":"/filing/0001005201-19-000099#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001663041","owner_name":"Bukofzer Stan","owner_display_name":"Bukofzer Stan","owner_url":"/insider/0001663041","role":"Officer (SVP, Chf Scitfc & Tech Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chf Scitfc & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chf Scitfc & Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.557,"price_display":"1.56","price_state":"stated","total_value":6228.0,"total_display":"6,228.00","total_whole":"6,228","shares_owned_after":26936.0,"shares_owned_after_display":"26,936","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-13","filed_date":"2019-08-14","scope":"insider"},{"id":8474304,"accession":"0001005201-19-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001005201-19-000045","line_url":"/filing/0001005201-19-000045#line-1","is_derivative":false,"issuer_cik":"0001005201","issuer_name":"Assertio Therapeutics, Inc","issuer_ticker":"ASRT","issuer_name_source":null,"issuer_url":"/issuer/0001005201","owner_cik":"0001663041","owner_name":"Bukofzer Stan","owner_display_name":"Bukofzer Stan","owner_url":"/insider/0001663041","role":"Officer (SVP, Chf Scitfc & Tech Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chf Scitfc & Tech Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chf Scitfc & Tech Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":4.1315,"price_display":"4.13","price_state":"stated","total_value":20657.5,"total_display":"20,657.50","total_whole":"20,658","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-14","filed_date":"2019-03-18","scope":"insider"},{"id":2219638,"accession":"0001274644-16-000136","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001274644-16-000136","line_url":"/filing/0001274644-16-000136#line-1","is_derivative":false,"issuer_cik":"0001274644","issuer_name":"Ocera Therapeutics, Inc.","issuer_ticker":"OCRX","issuer_name_source":null,"issuer_url":"/issuer/0001274644","owner_cik":"0001663041","owner_name":"Bukofzer Stan","owner_display_name":"Bukofzer Stan","owner_url":"/insider/0001663041","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.639,"price_display":"2.64","price_state":"stated","total_value":6597.5,"total_display":"6,597.50","total_whole":"6,598","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-13","filed_date":"2016-10-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001005201","name":"Assertio Therapeutics, Inc","url":"/issuer/0001005201","role":"Officer (SVP, Chf Scitfc & Tech Officer)","n_filings":2,"first_seen":"2019-03-18","last_seen":"2019-08-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001274644","name":"Ocera Therapeutics, Inc.","url":"/issuer/0001274644","role":"Officer (Chief Medical Officer)","n_filings":1,"first_seen":"2016-10-17","last_seen":"2016-10-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001663041","retrieved_at":"2026-08-24T21:18:10+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}